By altering the drug's formulation, researchers can improve its bioavailability, ensuring that a higher concentration of the drug reaches the cancer cells. This can be achieved through nanoparticle delivery systems, liposomal encapsulation, or altering the drug's solubility. Improved bioavailability can lead to better treatment outcomes with lower doses.